Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Home Dialysis Distribution topic
No spam. Unsubscribe anytime.
Committee releases bill to ease distribution rules for home dialysis supplies with pharmacist oversight
Summary
A2001 would exempt manufacturers and wholesale distributors from holding a separate pharmacy license when distributing dialysate for home dialysis, provided federal approvals, original sealed packaging, delivery on physician order, and periodic oversight by a licensed pharmacist. Industry witnesses said the change would remove duplicative regulations and expand access.
The Assembly Regulated Professions Committee on Monday released Assembly Bill A2001, a measure that seeks to reduce regulatory redundancy for distribution of dialysate and related supplies used in home dialysis.
Madeline read the bill, which would exempt drug manufacturers and wholesale drug distributors from a requirement to be licensed as a pharmacist when they distribute dialysate drugs or devices for home dialysis, if the products meet specified safeguards. The bill requires United States Food and Drug Administration approval for the drugs and devices, storage and delivery in original sealed labeled packaging, delivery only on receipt of a physician’s order to the patient or the patient’s designee, and periodic oversight of manufacturers and distributors by a licensed pharmacist.
Dennis Hart of State Street Associates and Vincent Hanks of Vantiv Corporation testified in support. Hart said the change is a “technical fix” to avoid duplicative licensing at the wholesaler level while preserving pharmacist oversight: “What this is about is home dialysis,” he said, and described patients receiving large pallets of dialysis fluid at home under physician direction. Hanks described the current supply chain and confirmed that dialysis fluid is treated as a drug that requires a prescription.
Witness slips were also filed by Laurie Clark of the New Jersey Pharmacists Association in favor. Committee members moved and, following a roll call, released the bill to the full Assembly.
Supporters said the bill would reduce operational friction and help expand home dialysis options while maintaining pharmacist oversight; questions about the specifics of oversight and implementation were not raised during the hearing.
